Pharmacology of Dyslipidemia Medications
125 Questions
10 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

Which of the following pharmacologic classes of dyslipidemia medications primarily influences the absorption of cholesterol?

  • Bile acid sequestrants (correct)
  • HMG-CoA reductase inhibitors
  • PCSK9 inhibitors
  • Fibrates

    • A patient is prescribed a medication that inhibits the enzyme responsible for the first step in cholesterol biosynthesis. Which of the following medication classes is this likely to belong to?

  • Fibrates
  • PCSK9 inhibitors
  • Bile acid sequestrants
  • HMG-CoA reductase inhibitors (correct)

    • Which of the following statements accurately describes the action of fibrates on lipid levels?

  • Fibrates primarily increase HDL-C and increase TG.
  • Fibrates primarily decrease LDL-C and increase HDL-C.
  • Fibrates primarily decrease LDL-C and decrease TG.
  • Fibrates primarily increase HDL-C and decrease TG. (correct)

    • Which of the following is a major drawback of using bile acid sequestrants for the long-term treatment of dyslipidemia?

    <p>They can cause severe gastrointestinal side effects.</p> Signup and view all the answers

    A patient is taking a medication that inhibits the absorption of cholesterol in the small intestine. Which of the following adverse effects is most likely to occur?

    <p>Increased LDL-C levels</p> Signup and view all the answers

    Which of the following statements accurately describes the mechanism of action of PCSK9 inhibitors?

    <p>They increase levels of LDL receptors and a reduction in LDL cholesterol levels</p> Signup and view all the answers

    A patient is taking a combination therapy for dyslipidemia, including a fibrate and a statin. Which of the following is a potential concern regarding this drug combination?

    <p>Increased risk of myopathy</p> Signup and view all the answers

    Which of the following statements accurately describes the role of bile acids in cholesterol metabolism?

    <p>Bile acids promote the absorption of cholesterol from the small intestine.</p> Signup and view all the answers

    What is the primary mechanism by which bile acids are reabsorbed from the intestines?

    <p>Active transport via a sodium-dependent transporter.</p> Signup and view all the answers

    How does the ionization state of bile acids influence their function as detergents?

    <p>Ionized bile acids are more effective detergents due to their increased polarity.</p> Signup and view all the answers

    Which of the following factors contributes to the decreased reabsorption of secondary bile acids?

    <p>Their increased polarity compared to primary bile acids.</p> Signup and view all the answers

    Which of the following statements accurately describes the role of bacterial flora in bile acid metabolism?

    <p>Bacterial flora contribute to the formation of secondary bile acids.</p> Signup and view all the answers

    What is the primary site of bile acid reabsorption in the gastrointestinal tract?

    <p>Ileum</p> Signup and view all the answers

    How often are bile acids recycled in the body on average?

    <p>6-8 times per day</p> Signup and view all the answers

    Which of the following best describes the role of LDL-C in the development of dyslipidemia?

    <p>Elevated LDL-C levels lead to inflammation and damage to blood vessel walls, contributing to atherosclerosis.</p> Signup and view all the answers

    Why is dyslipidemia considered a major health concern?

    <p>It is a major risk factor for a spectrum of cardiovascular diseases.</p> Signup and view all the answers

    What is the difference between primary and secondary dyslipidemia?

    <p>Primary dyslipidemia is genetic, while secondary dyslipidemia can be caused by other medical conditions or medications.</p> Signup and view all the answers

    What is the primary mechanism by which the ammonium cations function in bile acid sequestrants?

    <p>They exchange chloride ions with bile acids in the intestine.</p> Signup and view all the answers

    What significant side effects are associated with the use of bile acid sequestrants?

    <p>Constipation and bloating.</p> Signup and view all the answers

    Why was a new cholestyramine formulation developed?

    <p>To reduce the bulkiness added by suspending agents.</p> Signup and view all the answers

    What do anion-exchange resins contain that allows them to bind bile acids?

    <p>Positively charged functional groups.</p> Signup and view all the answers

    What is the appropriate method to take the powder form of bile acid sequestrants?

    <p>Stir into 2-6 ounces of non-carbonated liquid before consuming.</p> Signup and view all the answers

    What is the primary function of apolipoproteins in lipoproteins?

    <p>To act as ligands for cell receptors and cofactors for enzymes</p> Signup and view all the answers

    Which characteristic distinguishes high density lipoproteins from low density lipoproteins?

    <p>Higher percentage of proteins</p> Signup and view all the answers

    How are lipoproteins structured to enable lipids to dissolve in blood?

    <p>With a single phospholipid layer surrounding a hydrophobic core</p> Signup and view all the answers

    What kind of structural feature do apolipoproteins possess?

    <p>They exhibit an alpha-helical structure with amphipathic properties</p> Signup and view all the answers

    What is the role of free cholesterol within the lipoprotein structure?

    <p>To maintain membrane stability and decrease permeability</p> Signup and view all the answers

    In which location are apolipoproteins primarily produced?

    <p>In the liver</p> Signup and view all the answers

    What factor primarily determines the density class of a lipoprotein?

    <p>The ratio of lipids to proteins</p> Signup and view all the answers

    How do lipid-soluble vitamins relate to lipoprotein transport?

    <p>They are packaged within lipoproteins for Transport</p> Signup and view all the answers

    What is the primary structural difference between integral and peripheral apolipoproteins?

    <p>Integral apolipoproteins are embedded in the phospholipid layer, while peripheral ones are not</p> Signup and view all the answers

    What is the primary function of VLDL in the body?

    <p>To transport lipids from the liver to peripheral tissues.</p> Signup and view all the answers

    What percentage of triglycerides in VLDL is typically found in chylomicrons?

    <p>60%</p> Signup and view all the answers

    Which apolipoprotein is responsible for the activation of hepatic lipase and lipoprotein lipase?

    <p>ApoCII</p> Signup and view all the answers

    What stimulates the production of VLDL in the liver?

    <p>Excess glucose converted to free fatty acids.</p> Signup and view all the answers

    What role does ApoB play in the function of lipoproteins?

    <p>Facilitates endocytosis of LDL by the liver.</p> Signup and view all the answers

    Which of the following describes the composition of VLDL compared to chylomicrons?

    <p>VLDL contains more cholesterol and cholesteryl esters.</p> Signup and view all the answers

    What is lipogenesis and how is it regulated?

    <p>A process of fatty acid synthesis; mediated by insulin.</p> Signup and view all the answers

    How are chylomicrons converted to chylomicron remnants?

    <p>Via the hydrolysis of their triglycerides by lipoprotein lipase.</p> Signup and view all the answers

    What is the main source of free fatty acids that stimulate VLDL production?

    <p>An influx of free fatty acids into the liver.</p> Signup and view all the answers

    Which of the following receptors is NOT involved in the clearance of chylomicron remnants?

    <p>ApoCIII receptor</p> Signup and view all the answers

    A patient presents with a 10-year ASCVD risk of 6%. Based on the 2018 AHA/ACC Cholesterol Guideline, which of these treatment options is MOST appropriate?

    <p>No statin therapy is recommended.</p> Signup and view all the answers

    A patient is diagnosed with diabetes and has an LDL-C level of 160 mg/dL. They are 55 years old. What is the MOST appropriate statin therapy based on the 2018 AHA/ACC Cholesterol Guideline?

    <p>Moderate-intensity statin therapy is recommended.</p> Signup and view all the answers

    A patient with Clinical ASCVD has an LDL-C level of 100 mg/dL. Which type of statin therapy would be MOST appropriate for this patient?

    <p>High-intensity statin therapy is recommended.</p> Signup and view all the answers

    A patient with an LDL-C level of 200 mg/dL has no known history of ASCVD. Which of the following is MOST appropriate?

    <p>High-intensity statin therapy is recommended.</p> Signup and view all the answers

    Which of the following lipid-lowering medications would be MOST effective in reducing LDL-C by 50% or more?

    <p>High-intensity statins</p> Signup and view all the answers

    A patient is taking a moderate-intensity statin, and their LDL-C level has decreased to 110 mg/dL. Which of the following is the MOST appropriate next step in management?

    <p>Maintain the current statin therapy and monitor the patient's LDL-C levels regularly.</p> Signup and view all the answers

    Which of the following is a PRIMARY reason for treating patients with dyslipidemia?

    <p>To reduce the risk of developing or progressing ASCVD.</p> Signup and view all the answers

    A patient is diagnosed with dyslipidemia and has an LDL-C level of 160 mg/dL. They are 35 years old and have no known history of ASCVD. Which of the following statements is MOST accurate?

    <p>Further evaluation of ASCVD risk factors and a discussion of lifestyle modifications are appropriate.</p> Signup and view all the answers

    A patient has a family history of premature coronary heart disease. Which of the following is MOST appropriate for this patient?

    <p>Perform genetic testing for familial hypercholesterolemia.</p> Signup and view all the answers

    Which of these is NOT a common form of ASCVD?

    <p>Hypertension</p> Signup and view all the answers

    What is the primary mechanism by which bempedoic acid lowers LDL-C levels?

    <p>Inhibiting ATP-citrate lyase</p> Signup and view all the answers

    What is a major adverse effect associated with sustained-release niacin formulations?

    <p>Hepatotoxicity</p> Signup and view all the answers

    Which formulation of niacin is preferred for minimizing flushing while managing dyslipidemia?

    <p>Extended-Release</p> Signup and view all the answers

    What differentiates phase II drug metabolism from phase I drug metabolism?

    <p>Produces polar metabolites that are generally inactive</p> Signup and view all the answers

    In patients with ASCVD, what is the primary goal of secondary prevention strategies?

    <p>Preventing further cardiovascular events</p> Signup and view all the answers

    What is a key characteristic difference between PCSK9 monoclonal antibodies and siRNA therapy?

    <p>siRNA therapy inhibits PCSK9 synthesis at the genetic level</p> Signup and view all the answers

    Which of the following is a contraindication for the use of fibrates in treatment?

    <p>Severe renal impairment</p> Signup and view all the answers

    What effect do PCSK9 inhibitors have on LDL receptors?

    <p>Enhances the recycling of LDL receptors</p> Signup and view all the answers

    Which dietary factor can increase the risk of statin-related adverse effects?

    <p>Grapefruit juice consumption</p> Signup and view all the answers

    A patient with hypertriglyceridemia is prescribed a statin. Which of the following statins would be the most appropriate choice based on its metabolism profile?

    <p>Rosuvastatin</p> Signup and view all the answers

    A patient taking a statin experiences muscle pain and weakness. Which of the following factors could contribute to this side effect?

    <p>Concomitant use of a CYP3A4 inhibitor</p> Signup and view all the answers

    A patient with familial hypercholesterolemia is prescribed a bile acid sequestrant. Which of the following mechanisms explains how this medication lowers LDL-C levels?

    <p>Increased hepatic synthesis of bile acids</p> Signup and view all the answers

    A patient with severe hypertriglyceridemia is found to have triglycerides > 400 mg/dL. Which of the following statements is TRUE regarding the use of the Friedewald equation to estimate LDL-C in this patient?

    <p>The Friedewald equation is not valid for patients with triglycerides &gt; 400 mg/dL.</p> Signup and view all the answers

    A patient is prescribed lovastatin for hypercholesterolemia. What is the primary reason for the significant difference in bioavailability between lovastatin and rosuvastatin?

    <p>Lovastatin undergoes extensive first-pass metabolism in the liver.</p> Signup and view all the answers

    Which of the following statements accurately describes the function of fenofibrate in the treatment of dyslipidemia?

    <p>Fenofibrate reduces triglyceride levels by increasing lipoprotein lipase activity.</p> Signup and view all the answers

    Which of the following drugs is likely to increase plasma statin levels when co-administered with a statin medication?

    <p>Ketoconazole</p> Signup and view all the answers

    A patient is taking a statin medication and reports experiencing muscle pain. Which of the following would be the most appropriate action for the healthcare provider?

    <p>Reduce the statin dosage and monitor for improvement.</p> Signup and view all the answers

    Which of the following statements best explains why bile acid sequestrants are often used in combination with other lipid-lowering medications?

    <p>They work on different mechanisms to achieve a more significant reduction in LDL-C levels.</p> Signup and view all the answers

    A patient is prescribed a statin medication for primary prevention of cardiovascular disease. What is the primary rationale for this prescription?

    <p>To lower LDL-C levels and reduce the risk of cardiovascular events.</p> Signup and view all the answers

    What is the primary function of apoA1 in the context of HDL?

    <p>It stabilizes HDL by wrapping around it.</p> Signup and view all the answers

    Which process describes the removal of IDL particles from the blood?

    <p>ApoE-mediated receptor endocytosis</p> Signup and view all the answers

    What is the primary role of CETP in lipid metabolism?

    <p>It transfers cholesteryl esters between lipoproteins.</p> Signup and view all the answers

    Which lipoproteins are directly associated with apoB?

    <p>LDL and VLDL</p> Signup and view all the answers

    What condition can lead to secondary dyslipidemia?

    <p>Hypothyroidism</p> Signup and view all the answers

    What is the location for bile acid secretion in the gastrointestinal tract?

    <p>Duodenum</p> Signup and view all the answers

    What role does lipoprotein lipase play in lipid metabolism?

    <p>It metabolizes triglycerides.</p> Signup and view all the answers

    What substance is directly formed from HMG-CoA as a result of HMG-CoA reductase activity?

    <p>Mevalonate</p> Signup and view all the answers

    How are fatty acids transported in the blood apart from being in lipoproteins?

    <p>Complexed with albumin</p> Signup and view all the answers

    What is the role of enterocytes in lipid absorption?

    <p>They absorb monoacylglycerol.</p> Signup and view all the answers

    A patient presents with elevated triglyceride levels and is at risk for pancreatitis. Which of the following conditions is MOST likely contributing to this risk?

    <p>Obesity</p> Signup and view all the answers

    A patient with a history of hyperlipidemia is prescribed a statin medication. What is the PRIMARY mechanism by which this medication reduces LDL cholesterol levels?

    <p>Inhibition of the enzyme responsible for cholesterol biosynthesis</p> Signup and view all the answers

    A patient is diagnosed with corneal arcus. Which of the following lipid abnormalities is MOST likely associated with this condition?

    <p>Elevated LDL cholesterol</p> Signup and view all the answers

    A patient presents with symptoms of claudication and leg pain during exercise. Which of the following conditions is MOST likely associated with these symptoms?

    <p>Peripheral Artery Disease</p> Signup and view all the answers

    A patient with a history of hyperlipidemia is found to have a genetic predisposition to the condition. Which of the following factors is MOST likely responsible for this predisposition?

    <p>Increased activity of HMG-CoA reductase</p> Signup and view all the answers

    A physician is evaluating a patient with hyperlipidemia and is considering treatment options. Which of the following statin medications would be considered a HIGH-INTENSITY statin?

    <p>Atorvastatin (80mg)</p> Signup and view all the answers

    A patient with dyslipidemia is prescribed a medication that inhibits the absorption of cholesterol in the small intestine. Which of the following medication classes is this medication likely to belong to?

    <p>Bile acid sequestrants</p> Signup and view all the answers

    A patient is diagnosed with hyperlipidemia and is prescribed a combination therapy of a statin and a fibrate. Which of the following is a POTENTIAL CONCERN associated with this combination?

    <p>Increased risk of muscle toxicity</p> Signup and view all the answers

    A patient with hyperlipidemia is experiencing abdominal pain and discomfort. Which of the following conditions, associated with hyperlipidemia, is MOST likely contributing to these symptoms?

    <p>Pancreatitis</p> Signup and view all the answers

    A patient with a history of hyperlipidemia is being monitored for the development of atherosclerotic cardiovascular disease (ASCVD). Which of the following conditions is a MAJOR risk factor for ASCVD?

    <p>Diabetes Mellitus</p> Signup and view all the answers

    What is the primary function of lipoprotein lipase (LPL) in lipoprotein metabolism?

    <p>LPL hydrolyzes triglycerides in chylomicrons and VLDLs, releasing free fatty acids for energy or storage.</p> Signup and view all the answers

    Which of the following statements accurately describes the role of chylomicron remnants in lipoprotein metabolism?

    <p>Chylomicron remnants are taken up by the liver, where their cholesterol and triglycerides are metabolized.</p> Signup and view all the answers

    What is the primary mechanism by which high-density lipoproteins (HDL) contribute to reducing the risk of atherosclerosis?

    <p>HDL removes cholesterol from blood vessel walls and delivers it to the liver for excretion.</p> Signup and view all the answers

    Which of the following lipoprotein classes is primarily responsible for transporting triglycerides from the liver to peripheral tissues?

    <p>VLDLs</p> Signup and view all the answers

    Which of the following statements accurately describes the relationship between LDL cholesterol and atherosclerosis?

    <p>LDL cholesterol can accumulate in blood vessel walls, forming plaques that contribute to atherosclerosis.</p> Signup and view all the answers

    Which of the following is a key difference between chylomicrons and very-low-density lipoproteins (VLDLs)?

    <p>Chylomicrons transport dietary lipids from the intestines to the liver, while VLDLs transport lipids synthesized by the liver to peripheral tissues.</p> Signup and view all the answers

    What is the primary mechanism by which the liver regulates cholesterol levels in the blood?

    <p>The liver secretes bile acids, which help to excrete cholesterol from the body.</p> Signup and view all the answers

    Which of the following accurately describes the process of foam cell formation in atherosclerosis?

    <p>Foam cells are formed when macrophages engulf oxidized LDL cholesterol, leading to the accumulation of cholesterol esters within the cells.</p> Signup and view all the answers

    Which of the following lipoprotein classes is most closely associated with high triglyceride levels in the blood?

    <p>Chylomicrons</p> Signup and view all the answers

    What is the primary function of HMG-CoA Reductase in cholesterol metabolism?

    <p>Converts HMG-CoA to mevalonate</p> Signup and view all the answers

    Which enzyme is inhibited by PCSK9, leading to reduced LDL receptor availability?

    <p>LDL Receptor</p> Signup and view all the answers

    What role does Lecithin-Cholesterol Acyltransferase (LCAT) play in lipid metabolism?

    <p>Converts free cholesterol to cholesteryl esters</p> Signup and view all the answers

    Which of the following best describes the role of ATP-Binding Cassette Transporter A1 (ABCA1)?

    <p>Transfers cholesterol to nascent HDL for reverse cholesterol transport</p> Signup and view all the answers

    How does lipoprotein lipase (LPL) function in lipid metabolism?

    <p>Hydrolyzes triglycerides for cellular uptake</p> Signup and view all the answers

    In which scenario would high-intensity statins be recommended according to ASCVD guidelines?

    <p>For secondary prevention in patients with clinical ASCVD</p> Signup and view all the answers

    What is the effect of activating ApoC-II on lipoprotein metabolism?

    <p>Enhances triglyceride hydrolysis by LPL</p> Signup and view all the answers

    What describes the action of Cholesteryl Ester Transfer Protein (CETP)?

    <p>Transfers cholesteryl esters from HDL to LDL and VLDL</p> Signup and view all the answers

    Which enzyme plays a crucial role in the hydrolysis of triglycerides in VLDL?

    <p>Lipoprotein Lipase (LPL)</p> Signup and view all the answers

    What is the role of Cholesterol 7α-Hydroxylase (CYP7A1) in lipid metabolism?

    <p>Converts cholesterol into bile acids.</p> Signup and view all the answers

    How does Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) affect LDL receptors?

    <p>It degrades LDL receptors, reducing their availability for LDL-C clearance.</p> Signup and view all the answers

    What is the activation mechanism of Lipoprotein Lipase (LPL)?

    <p>Inhibited by apoC-III and activated by apoC-II.</p> Signup and view all the answers

    Which receptor facilitates the hepatic uptake of apoE-containing lipoproteins?

    <p>ApoE Receptor</p> Signup and view all the answers

    In the context of managing dyslipidemia, what is the goal for LDL-C reduction in primary prevention?

    <p>Achieve a 50% reduction in LDL-C levels.</p> Signup and view all the answers

    What is one of the key clinical targets of statins in dyslipidemia management?

    <p>Inhibit HMG-CoA Reductase.</p> Signup and view all the answers

    What does the ATP-Binding Cassette Transporter A1 (ABCA1) do in lipid metabolism?

    <p>Transfers cholesterol to nascent HDL for reverse cholesterol transport.</p> Signup and view all the answers

    Which enzyme is involved in the transfer of cholesteryl esters between lipoproteins?

    <p>Cholesteryl Ester Transfer Protein (CETP)</p> Signup and view all the answers

    What is the primary function of HMG-CoA reductase in cholesterol biosynthesis?

    <p>Catalyzes the conversion of HMG-CoA to mevalonate.</p> Signup and view all the answers

    Which of the following enzymes is primarily activated by apoC-II?

    <p>Lipoprotein Lipase (LPL)</p> Signup and view all the answers

    What is the role of Scavenger Receptor Class B Type I (SR-B1) in lipid metabolism?

    <p>Facilitates uptake of cholesteryl esters from HDL to the liver.</p> Signup and view all the answers

    Which enzyme is involved in the synthesis of bile acids from cholesterol in the liver?

    <p>Cholesterol 7α-Hydroxylase (CYP7A1)</p> Signup and view all the answers

    According to ASCVD guidelines for primary prevention, which statin regimen is recommended for patients with high risk?

    <p>High-intensity statins achieving ≥50% LDL-C reduction.</p> Signup and view all the answers

    What is the primary action of Lecithin-Cholesterol Acyltransferase (LCAT)?

    <p>Esterifies free cholesterol to cholesteryl esters in HDL.</p> Signup and view all the answers

    What clinical target has been associated with the enzyme HMG-CoA reductase?

    <p>Reduction of LDL-C levels through statin inhibition.</p> Signup and view all the answers

    Which receptor primarily mediates the cellular uptake of LDL particles?

    <p>LDL Receptor (LDLR)</p> Signup and view all the answers

    What is the function of Acyl Coenzyme A: Cholesterol Acyltransferase (ACAT)?

    <p>Esterifies free cholesterol for storage.</p> Signup and view all the answers

    Study Notes

    Dyslipidemia Part 1 Learning Objectives

    • Describe the incidence and impact of CVD in the US, including current trends in event and death rates.
    • Detail the steps in triglyceride and cholesterol digestion and absorption.
    • Define the differences between cholesterol and cholesteryl esters.
    • Define a lipoprotein, describing the role of each component in a lipoprotein particle.
    • Differentiate between the major lipoprotein groups—chylomicrons, chylomicron remnants, VLDL, IDL, LDL, and HDL.
    • Identify the major apolipoproteins and lipids associated with each lipoprotein, their biological role, and metabolic fates.
    • Detail the liver's role in lipid transport and metabolism, including apoE- and apoB-mediated receptor endocytosis.
    • Describe the reverse cholesterol transport pathway and the role of cholesteryl ester transfer protein in cholesterol transport from HDL.
    • Explain cholesterol acquisition by the body.
    • Summarize the biochemical steps for cholesterol synthesis, highlighting HMG-CoA reductase's role.
    • Define the roles of apoAl, apoB, apoCII, apoCIII, and apoE in lipoproteins.
    • Describe cholesterol transport in the blood and excretion from the body.
    • Outline bile acid synthesis, structure, and function.
    • Differentiate between hypercholesterolemia, hypertriglyceridemia, and combined hypercholesterolemia and hypertriglyceridemia.
    • Explain the difference between primary and secondary dyslipidemia.
    • Identify common causes of secondary dyslipidemia.
    • Summarize the steps involved in atherosclerosis formation, identifying the role of LDL-C in the process.
    • Describe how dyslipidemia medications affect TG and cholesterol synthesis or absorption by various mechanisms.
    • Describe how dyslipidemia medications change LDL-C, HDL-C and TG levels.
    • Identify the pharmacologic classification of various dyslipidemia medications.
    • Describe the general effects of various dyslipidemia medications on LDL-C, HDL-C, and TG.

    Dyslipidemia Rat 2 Learning Objectives

    • Calculate LDL-C using the Friedewald equation, and when the equation is not valid.
    • Describe first-pass metabolism, its impact on oral bioavailability of HMG-CoA reductase inhibitors, and their metabolism/excretion pathways.
    • Detail the bioactivation of lovastatin, simvastatin, and fenofibrate.
    • Describe anion-exchange process in bile acid sequestrants and bile acid.
    • Differentiate between nicotinic acid and nicotinamide
    • Describe the metabolism of various formulations of niacin.
    • Identify two active components of fish oil for dyslipidemia management (EPA and DHA).
    • Summarize FDA-approved indications for PCSK9 inhibitors (reducing cardiovascular events in patients with established CVD or DM with additional CVD risk factors, and as adjunctive therapy for primary hyperlipidemia, including heterozygous familial hypercholesterolemia).
    • Discuss similarities/differences in mechanisms and effects of PCSK9 mAbs and PCSK9 siRNA therapy (siRNA targets and degrades mRNA for PCSK9, while monoclonal antibodies bind and inhibit PCSK9 activity).
    • Compare/contrast the mechanisms and effects of bempedoic acid and statins (bempedoic acid inhibits ATP-citrate lyase, thus reducing cholesterol synthesis).
    • Describe drug metabolism profiles of dyslipidemia drugs (including CYP450 interactions, and potential for drug-drug interactions).
    • Identify contraindications for dyslipidemia medications (include liver and kidney disease, pregnancy).
    • Identify drug-drug/food/disease interactions involving dyslipidemia medications.
    • Differentiate between primary and secondary prevention of ASCVD (primary prevention focuses on patients who have never had a cardiovascular event, while secondary prevention focuses on those who have already).
    • Identify and describe clinical forms of ASCVD (coronary artery disease, angina, myocardial infarction, acute coronary syndrome, cerebrovascular disease, transient ischemic attack, peripheral artery disease, and abdominal aortic aneurysm).
    • Identify the primary goal for treating patients with dyslipidemia (prevent ASCVD, and modify lipoprotein concentrations based on individual risk).
    • Describe the relationship between LDL-C and ASCVD (higher LDL-C increases risk).
    • Describe 4 patient management groups that benefit from lipid-altering therapy (secondary ASCVD prevention, severe hypercholesterolemia, diabetes mellitus, and primary prevention).
    • Describe low-, moderate-, and high-intensity statin therapy (LDL-C reduction ≥50% [high], 30-49% [moderate], <30% [low]).
    • Classify a given statin/dosage according to intensity.
    • Describe the system utilized to grade recommendations based on strength & evidence (ACC/AHA Cholesterol Guideline).
    • Describe recommended treatment/intensity for secondary prevention and additional therapies to reduce ASCVD outcomes.
    • Explain the evidence-based approach to treat severe hypercholesterolemia .
    • Explain the recommended treatment for patients with diabetes and personalization of therapy based on age, 10-year ASCVD risk, and diabetes risk enhancers (consider 10-year risk and risk-enhancing factors, and use either moderate or high-intensity statins).
    • List risk factors used in the Pooled Cohort Equations to estimate 10-year ASCVD risk.
    • Calculate 10-year ASCVD risk.
    • Classify patients into appropriate risk categories based on 10-year ASCVD risk in primary prevention (low, borderline, intermediate, high).
    • Explain limitations of the Pooled Cohort Equations for ASCVD risk assessment (age is a strong population risk factor, but does not necessarily reflect every individual patient's risk).
    • Analyze why statins are first-line therapy for dyslipidemia, identifying other medications with evidence to reduce ASCVD risk, and
    • Recommend treatment for patients with varying severities of hypertriglyceridemia (consider lifestyle modifications first, statins as primary, fibrates or omega-3s for very high TG levels).
    • Create a plan to monitor effectiveness and adverse effects of lipid-lowering medications (regular lipid panels, liver function tests, creatine kinase monitoring for muscle effects, blood glucose for diabetes risks).
    • Explain strategies for minimizing adverse effects of various dyslipidemia medications, used alone or in combination (dose titration, combinations with caution, consideration of specific risks based on comorbidities).
    • Summarize non-pharmacologic therapies to improve lipids (diet modifications, exercise, weight reduction, and smoking cessation).
    • Develop a therapeutic plan for dyslipidemia treatment incorporating pharmacologic and non-pharmacologic therapies to prevent ASCVD (based on patient risk factors, tolerated medications, comorbidities).
    • Explain rationale for selecting pharmacologic and non-pharmacologic interventions to treat dyslipidemia (evidence-based approach considering patient specifics).
    • Add a section about monitoring for safety and effectiveness of lipid-modifying medications, including frequency, tests, and what to do when therapeutic goals aren't met, including specific tests (e.g., LFTs, CK), and rationale for testing (e.g., baseline LFT for all, and subsequent testing when signs of hepatotoxicity or myopathy are present; fasting glucose/HbA1c at baseline and periodically for diabetes concerns).
    • Include considerations for specific populations regarding dyslipidemia management (e.g., children, pregnant women, older adults, those with kidney or liver disease, or those with other comorbidities, and ethnic groups).

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    IP3 Dyslipidemia 2025 Final PDF
    Dyslipidemia Family Feud PDF

    Description

    This quiz explores various pharmacologic classes of dyslipidemia medications, focusing on their mechanisms, actions, and potential drawbacks. Test your knowledge on cholesterol absorption inhibitors, fibrates, statins, and combination therapies for effective dyslipidemia management.

    More Like This

    Use Quizgecko on...
    Browser
    Open
    Browser
    Browser